Inebilizumab for treatment of neuromyelitis optica spectrum disorder in patients with prior rituximab use from the N-MOmentum Study

by Cimbora, D., Cree, B.A.C, Drappa, J., Flanagan, E.P, Katz, E., Levy, M., Mealy, M.A, She, D.
Published 2022